Qube Research & Technologies LTD Atri Cure, Inc. Transaction History

Qube Research & Technologies LTD

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$19.86 - $29.09 $3.82 Million - $5.59 Million	-192,213 Reduced 89.72%	22,019 $501,000
Q1 2024 May 14, 2024	SELL	$28.21 - $37.78 $315,613 - $422,682	-11,188 Reduced 4.96%	214,232 $6.52 Million
Q4 2023 Feb 13, 2024	BUY	$32.99 - $43.25 $4.1 Million - $5.37 Million	124,223 Added 122.75%	225,420 $8.05 Million
Q3 2023 Nov 13, 2023	BUY	$41.12 - $57.73 $795,918 - $1.12 Million	19,356 Added 23.65%	101,197 $4.43 Million
Q2 2023 Aug 14, 2023	BUY	$40.44 - $49.6 $1.47 Million - $1.81 Million	36,420 Added 80.18%	81,841 $4.04 Million
Q1 2023 May 15, 2023	BUY	$35.87 - $47.22 $1.63 Million - $2.14 Million	45,421 New	45,421 $1.88 Million
Q2 2022 Aug 15, 2022	SELL	$35.1 - $66.01 $751,631 - $1.41 Million	-21,414 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$57.43 - $71.39 $765,943 - $952,128	13,337 Added 165.12%	21,414 $1.41 Million
Q4 2021 Feb 01, 2022	BUY	$63.4 - $87.14 $512,081 - $703,829	8,077 New	8,077 $562,000
Q3 2020 Nov 12, 2020	SELL	$38.36 - $46.91 $1.04 Million - $1.27 Million	-27,019 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$31.78 - $51.19 $858,663 - $1.38 Million	27,019 New	27,019 $1.22 Million

212

49.7M

12K

7.2K

Ticker ATRC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 46,424,700
Market Cap $1.67B
Description
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.